Overview
Russell Laforte is a primary care provider, practicing in Family Medicine and Internal Medicine in Galveston, Texas. Dr. Laforte is rated as an Experienced provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Obesity, Tenosynovitis, Obesity in Children, Liver Embolization, and Endoscopy. Dr. Laforte is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
301 University Blvd, Galveston, TX 77555
Utmb Faculty Group Practice
Syed Azhar is a primary care provider, practicing in Family Medicine in Galveston, Texas. Dr. Azhar is rated as an Advanced provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Azhar is currently accepting new patients.
Utmb Faculty Group Practice
Karl Crudo is a primary care provider, practicing in Family Medicine in League City, Texas. Dr. Crudo is rated as an Advanced provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Crudo is currently accepting new patients.
James Bernick is a primary care provider, practicing in Family Medicine and Geriatrics in Baytown, Texas. Dr. Bernick is rated as an Advanced provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Tracheitis, Hypertensive Heart Disease, Chronic Obstructive Pulmonary Disease (COPD), Pacemaker Implantation, and Endoscopy. Dr. Bernick is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Hepatic Porphyria (AHP)Dr. Laforte isAdvanced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Laforte isAdvanced. Learn about Acute Intermittent Porphyria.
- End-Stage Renal Disease (ESRD)Dr. Laforte isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Familial HypertensionDr. Laforte isAdvanced. Learn about Familial Hypertension.
- Glucocorticoid-Remediable Aldosteronism
- HypertensionDr. Laforte isAdvanced. Learn about Hypertension.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Laforte isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute CystitisDr. Laforte isExperienced. Learn about Acute Cystitis.
- Acute Kidney FailureDr. Laforte isExperienced. Learn about Acute Kidney Failure.
- Acute PancreatitisDr. Laforte isExperienced. Learn about Acute Pancreatitis.
- Alcoholic CirrhosisDr. Laforte isExperienced. Learn about Alcoholic Cirrhosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Laforte isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.